These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8139592)

  • 1. Bilateral akinesia in drug-induced parkinsonism after a subthalamic lesion.
    Kulisevsky J; Lima de Freitas M; Barraquer-Bordas L
    Mov Disord; 1994 Jan; 9(1):111-2. PubMed ID: 8139592
    [No Abstract]   [Full Text] [Related]  

  • 2. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate.
    Aziz TZ; Peggs D; Sambrook MA; Crossman AR
    Mov Disord; 1991; 6(4):288-92. PubMed ID: 1758446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism.
    Giladi N; Melamed E
    Mov Disord; 1999 Jan; 14(1):158-9. PubMed ID: 9918362
    [No Abstract]   [Full Text] [Related]  

  • 4. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment.
    Benazzouz A; Boraud T; Féger J; Burbaud P; Bioulac B; Gross C
    Mov Disord; 1996 Nov; 11(6):627-32. PubMed ID: 8914087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral disappearance of parkinsonian signs after subthalamic hematoma.
    Sellal F; Hirsch E; Lisovoski F; Mutschler V; Collard M; Marescaux C
    Neurology; 1992 Jan; 42(1):255-6. PubMed ID: 1734311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.
    Petzinger GM; Bressman SB
    Mov Disord; 1997 Mar; 12(2):246-8. PubMed ID: 9087987
    [No Abstract]   [Full Text] [Related]  

  • 7. Parkinsonism and tardive dyskinesia after chronic use of clebopride.
    Sempere AP; Duarte J; Palomares JM; Coria F; Clavería LE
    Mov Disord; 1994 Jan; 9(1):114-5. PubMed ID: 8166880
    [No Abstract]   [Full Text] [Related]  

  • 8. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenytoin and dyskinesias: a report of two cases and review of the literature.
    Harrison MB; Lyons GR; Landow ER
    Mov Disord; 1993; 8(1):19-27. PubMed ID: 8419804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: new surgical perspectives.
    Guridi J; Obeso JA
    Adv Neurol; 1997; 74():235-47. PubMed ID: 9348418
    [No Abstract]   [Full Text] [Related]  

  • 11. Stimulus-sensitive paroxysmal dyskinesias associated with a thalamic infarct.
    Nijssen PC; Tijssen CC
    Mov Disord; 1992 Oct; 7(4):364-6. PubMed ID: 1484533
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.
    Blanchet PJ; Grondin R; Bédard PJ
    Mov Disord; 1996 Jan; 11(1):91-4. PubMed ID: 8771074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia and pseudo-parkinsonism. In a nursing home patient who itched.
    Ondo WG; Hurwitz BJ
    N C Med J; 1993 Nov; 54(11):605-7. PubMed ID: 8272117
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical grading of neurological symptoms in thalamic hemorrhage].
    Kuroda K; Ogawa A
    Nihon Rinsho; 1993 Dec; 51 Suppl():148-53. PubMed ID: 8120975
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemiballism in multiple sclerosis.
    Riley D; Lang AE
    Mov Disord; 1988; 3(1):88-94. PubMed ID: 3050474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
    Furukawa Y; Nishi K; Kondo T; Mizuno Y; Narabayashi H
    Adv Neurol; 1993; 60():562-7. PubMed ID: 8420192
    [No Abstract]   [Full Text] [Related]  

  • 17. Cinnarizine-induced parkinsonism: ten years later.
    Martí-Massó JF; Poza JJ
    Mov Disord; 1998 May; 13(3):453-6. PubMed ID: 9613736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamic lacune and contralateral hemiparkinsonism subsequently relieved by spontaneous thalamo-subthalamic hematoma.
    de la Fuente Fernández R
    Mov Disord; 1995 Jan; 10(1):116-7. PubMed ID: 7885348
    [No Abstract]   [Full Text] [Related]  

  • 19. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
    Pearce RK; Banerji T; Jenner P; Marsden CD
    Mov Disord; 1998 Mar; 13(2):234-41. PubMed ID: 9539335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating levodopa-induced dyskinesias in the parkinsonian primate.
    Langston JW; Quik M; Petzinger G; Jakowec M; Di Monte DA
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S79-89. PubMed ID: 10762135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.